These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4132883)

  • 21. Nephrotoxic potential of Bence Jones proteins.
    Solomon A; Weiss DT; Kattine AA
    N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin origin of amyloid.
    Lancet; 1973 May; 1(7811):1046. PubMed ID: 4122121
    [No Abstract]   [Full Text] [Related]  

  • 23. Proceedings: The complete amino acid sequence of a rat kappa-light chain.
    Starace V; Querinjean P; Bazin H; Beckers A; Manteuffel M; Heremans JF
    Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1259. PubMed ID: 4218837
    [No Abstract]   [Full Text] [Related]  

  • 24. [Myeloma as a tool for elucidation of the mechanism of antibody diversity].
    Laskov R
    Harefuah; 1972 Jan; 82(2):78-85. PubMed ID: 4565408
    [No Abstract]   [Full Text] [Related]  

  • 25. [Principle of antibody structure. The primary structure of a monoclonal kappa I-type immunoglobulin L-chain aggregate forms, (Bence Jones protein Bi). I. Purification, and characterization of the protein].
    Leibold W; Braun M; Gottschalk EM; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1972 Aug; 353(8):1259-72. PubMed ID: 4628263
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental murine amyloid. IV. Amyloidosis and immunoglobulins.
    Willerson JT; Asofsky R; Barth WF
    J Immunol; 1969 Oct; 103(4):741-9. PubMed ID: 4186916
    [No Abstract]   [Full Text] [Related]  

  • 27. Amino acid sequence change associated with genetic marker Inv(2) of human immunoglobulin.
    Milstein CP; Steinberg AG; McLaughlin CL; Solomon A
    Nature; 1974 Mar; 248(5444):160-1. PubMed ID: 4132042
    [No Abstract]   [Full Text] [Related]  

  • 28. [The primary structure of a monoclonic immunoglobulin-L-chain of subgroup IV of the kappa type (Bence-Jones protein Len.)].
    Schneider M; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1975 May; 356(5):507-57. PubMed ID: 50995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bence-Jones proteins and light chains of immunoglobulins (second of two parts).
    Solomon A
    N Engl J Med; 1976 Jan; 294(2):91-8. PubMed ID: 53788
    [No Abstract]   [Full Text] [Related]  

  • 30. [The primary structure of a crystalline, monoclonal immunoglobulin-L-chain of the kappa type, subgroup I (Bence-Jones protein Rei): a contribution to the elucidation of the three-dimensional structure of the immunoglobulins (author's transl)].
    Palm W; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1973 Dec; 354(12):1651-4. PubMed ID: 4215722
    [No Abstract]   [Full Text] [Related]  

  • 31. Current concepts of the formation and composition of amyloid.
    Glenner GG
    Ann Clin Lab Sci; 1975; 5(4):257-63. PubMed ID: 808999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Principle of antibody structure. The primary structure of a monoclonal kappa I-type immunoglobulin L-chain (Bence Jones protein Bi). 3. The complete aminno acid sequence and the genetic significance of the variability principles for the mechanism of antibody formation].
    Braun M; Leibold W; Barnikol HU; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1972 Aug; 353(8):1284-306. PubMed ID: 4563064
    [No Abstract]   [Full Text] [Related]  

  • 33. Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence Jones proteins.
    Solomon A; Schmidt W; Havemann K
    J Immunol; 1976 Sep; 117(3):1010-4. PubMed ID: 60445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biochemical characterization of 2 Bence Jones proteins, kappa and lambda, produced by the same patient].
    Gibaud A; Lacroix C; Fougereau M
    Ann Inst Pasteur (Paris); 1972 Jul; 123(1):149. PubMed ID: 4640728
    [No Abstract]   [Full Text] [Related]  

  • 35. AA amyloidosis and AL amyloidosis.
    Isobe T
    Intern Med; 1993 Dec; 32(12):919-20. PubMed ID: 8204969
    [No Abstract]   [Full Text] [Related]  

  • 36. [Modern studies in renal amyloidosis].
    Atanasova P
    Vutr Boles; 1979; 18(4):1-7. PubMed ID: 386619
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro production of an amyloid-like substance from gamma 3 heavy chain disease protein.
    Pruzanski W; Katz A; Nyburg SC; Freedman MH
    Immunol Commun; 1974; 3(5):469-76. PubMed ID: 4609897
    [No Abstract]   [Full Text] [Related]  

  • 38. [Amyloidosis: an immunoproliferative disease].
    Lovisetto P; Ricci C; Marchi L; Biarese V
    Recenti Prog Med; 1973 Sep; 55(3):229-48. PubMed ID: 4203558
    [No Abstract]   [Full Text] [Related]  

  • 39. [Principle of antibody structure. The structure of a monoclonal kappa I-type immunoglobulin L-chain (Bence Jones protein Bi). II. Isolation and characterization of the tryptic peptides].
    Braun M; Leibold W; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1972 Aug; 353(8):1273-83. PubMed ID: 5082084
    [No Abstract]   [Full Text] [Related]  

  • 40. [Light chain deposition disease].
    Kanoh T
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):585-7. PubMed ID: 9851224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.